Clinical Research Directory

Inclusion Criteria: 1. Delivery of an informed consent form signed and dated by parents or guardian and patient 2. Declared willingness to comply with all study procedures and availability for the duration of the study. 3. provision of appropriate consent and assent 4. Willingness and ability to participate in study procedures 5. Patients under 18 years of age 6. Full-term pregnancies (37-41 Weeks of Gestation). 7. Nulliparity 8. Have your own cell phone 9. Know how to read and write 10. Residing in Tegucigalpa 11. Be in good general health, as evidenced by your medical history 12. Ultrasound with amniotic fluid index \> 5 cm 13. Non Stress Test Reactive 14. Ability to take oral medication and be willing to comply with the cinnamon capsule regimen Exclusion Criteria: 1. Current use of antihypertensive or hypoglycemic medications 2. Presence of non-curable chronic diseases prior to pregnancy or during pregnancy such as hypertension, diabetes, hypothyroidism 3. Premature rupture of membranes 4. Infections (urinary tract infection, chorioamnionitis) present at the time of the study (diagnosed with symptoms or leukocytes \>12,500 or pathological urine examination) 5. Allergies to cinnamaldehyde or cinnamon, canola oil 6. Multiple pregnancy 7. Major fetal malformations 8. Fetal death 9. Non-cephalic presentation 10. Severe oligohydramnios (amniotic fluid index \< 2 cm) 11. Having consumed or being consuming cinnamon products 7 days before the start of the study 12. Febrile illness within 7 days before starting to take cinnamon 13. Treatment with another investigational drug or other intervention within 7 days prior to the start of the intervention 14. Current smoker or tobacco use